Blunted arginine vasopressin secretion in individuals experiencing a major depressive episode with comorbid post‐traumatic stress disorder: Results from an exploratory study using copeptin as a surrogate marker
Journal of Neuroendocrinology · 2026
DOI: 10.1111/jne.70133 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Journal of Neuroendocrinology, 2026. Verfasst von Hiroe Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health…. Hauptthemen laut MEDLINE: Arginine Vasopressin, Glycopeptides, Major Depressive Disorder, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: NIMH NIH HHS, American Foundation for Suicide Prevention, National Institute of Mental Health.
Abstract (Originalsprache)
Arginine vasopressin (AVP) modulates stress responsivity and social‐affective behaviors, but its role in mood and trauma‐related disorders remains poorly defined due to challenges in peripheral measurement. This study used copeptin, a stable, reliable, and well‐validated surrogate marker of AVP secretion, to assess vasopressinergic function in a transdiagnostic sample of individuals experiencing a major depressive episode (MDE) with and without post‐traumatic stress disorder (PTSD), as well as healthy volunteers (HVs). Baseline levels of copeptin, corticotropin‐releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and urine cortisol were compared across groups and examined in relation to clinical symptoms and behavioral traits. Acute changes in copeptin and other hypothalamic–pituitary–adrenal axis markers following a single subanesthetic‐dose ketamine infusion were also investigated in a subset of patients. Participants with MDE + PTSD exhibited significantly lower baseline copeptin levels and a blunted reduction in copeptin levels post‐ketamine compared to MDE‐only participants. Copeptin was unrelated to primary mood diagnosis and to symptom severity of depression, anxiety, post‐traumatic stress, anhedonia, suicidal ideation, childhood trauma history, or behavioral traits other than aggression. Higher baseline copeptin levels were associated with verbal aggression, and PTSD comorbidity attenuated these associations. Collectively, these findings suggest a possible biological subtype of attenuated AVP secretion in the dual diagnostic subgroup of co‐occurring MDE and PTSD that is independent of symptom burden. Plasma copeptin might therefore serve not only as a peripheral biomarker but also as a proxy for central neuromodulatory changes relevant to AVP‐driven circuits in the study of neuropsychiatric disorders. Future studies integrating the temporal dynamics of copeptin with neuroimaging, genetic, and stress‐challenge paradigms are needed to delineate the potential neural pathways through which AVP contributes to the pathophysiology and treatment responsiveness of mood and trauma‐related disorders. Clinical Trial Registration: www.clinicaltrials.gov (NCT02543983).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Endocrinology, Georgetown University, Washington, District of Columbia, USA.
ORCID-Profile: Hiroe Hu, Laura Waldman
Förderung
- NIMH NIH HHS
- American Foundation for Suicide Prevention
- National Institute of Mental Health
Zitieren
APA
Hu, H., Lee, Y., Tillman, A. N., Ballard, E. D., Waldman, L., Yuan, P., Johnston, J. N., Peng, S., Kvarta, M. D., Verbalis, J. G., & Zarate, C. A. (2026). Blunted arginine vasopressin secretion in individuals experiencing a major depressive episode with comorbid post‐traumatic stress disorder: Results from an exploratory study using copeptin as a surrogate marker. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.70133
Vancouver
Hu H, Lee Y, Tillman AN, Ballard ED, Waldman L, Yuan P, et al. Blunted arginine vasopressin secretion in individuals experiencing a major depressive episode with comorbid post‐traumatic stress disorder: Results from an exploratory study using copeptin as a surrogate marker. Journal of Neuroendocrinology. 2026. doi:10.1111/jne.70133
BibTeX
@article{Hu2026,
author = {Hu, Hiroe and Lee, Yoojin and Tillman, Alaina N and Ballard, Elizabeth D and Waldman, Laura and Yuan, Peixiong and Johnston, Jenessa N and Peng, Shiyong and Kvarta, Mark D and Verbalis, Joseph G and Zarate, Carlos A},
title = {Blunted arginine vasopressin secretion in individuals experiencing a major depressive episode with comorbid post‐traumatic stress disorder: Results from an exploratory study using copeptin as a surrogate marker},
journal = {Journal of Neuroendocrinology},
year = {2026},
doi = {10.1111/jne.70133}
}
EUVIMED